| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 110.34B | 104.02B | 97.61B | 88.78B | 81.48B | 74.87B |
| Gross Profit | 68.92B | 63.79B | 58.00B | 52.72B | 49.86B | 44.15B |
| EBITDA | 63.94B | 59.49B | 54.18B | 49.07B | 47.20B | 43.34B |
| Net Income | 40.46B | 37.64B | 32.91B | 30.01B | 29.75B | 4.02B |
Balance Sheet | ||||||
| Total Assets | 245.94B | 268.34B | 272.64B | 243.62B | 230.76B | 210.98B |
| Cash, Cash Equivalents and Short-Term Investments | 91.48B | 116.22B | 112.01B | 95.69B | 82.38B | 70.77B |
| Total Debt | 2.36B | 2.25B | 2.66B | 2.42B | 2.83B | 3.17B |
| Total Liabilities | 46.19B | 60.98B | 73.61B | 49.47B | 48.28B | 37.45B |
| Stockholders Equity | 196.51B | 204.20B | 196.00B | 191.46B | 180.34B | 171.83B |
Cash Flow | ||||||
| Free Cash Flow | 43.43B | 35.39B | 45.05B | 32.81B | 35.50B | 33.17B |
| Operating Cash Flow | 47.32B | 38.16B | 47.15B | 36.91B | 36.63B | 38.41B |
| Investing Cash Flow | -14.91B | -6.00B | -2.65B | -9.07B | -1.34B | -9.33B |
| Financing Cash Flow | -41.21B | -29.95B | -28.19B | -17.12B | -24.68B | -15.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥817.47B | 19.01 | 19.13% | 2.64% | 7.58% | 15.12% | |
66 Neutral | ¥146.59B | 8.08 | ― | 2.82% | 11.66% | -7.47% | |
63 Neutral | ¥59.16B | 10.40 | ― | 4.49% | 8.56% | -13.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥27.24B | 9.94 | ― | 4.79% | -6.89% | -50.31% | |
53 Neutral | ¥271.09B | 19.04 | ― | 1.24% | 21.79% | 9.89% | |
48 Neutral | ¥4.10B | -10.59 | ― | 1.08% | -2.36% | -1738.42% |